KRBP   $1.45  -7.64% Market Closed

Kiromic BioPharma Inc
Total Cash 3.20M
totalCashPerShare 2.487
EBITDA -17.72M
Total Debt 15.54M
quickRatio 0.157
currentRatio 0.217
Total Revenue
debtToEquity
Revenue/Share
ROA -1.03263
ROE
grossProfits
freeCashflow -14.23M
operatingCashflow -21.23M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 16.01M
forwardPE
floatShares 1.01M
sharesOutstanding 1.29M
sharesShort 45.74K
sharesShortPriorMonth 62.44K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.00%
Short Ratio help_outline 1.45%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue -7.248
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -23.50M
trailingEps -12.59%
forwardEps -1.55%
enterpriseToEbitda -0.90
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2022
institutionsCount 1
lastUpdated April 1, 2024, 2:50 p.m.